Carlos
Diéguez González
Instituto de Biomedicina de Sevilla
Sevilla, EspañaPublications in collaboration with researchers from Instituto de Biomedicina de Sevilla (1)
2022
-
Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function
Journal of Hepatology, Vol. 76, Núm. 1, pp. 11-24